Tilmicosin: Difference between revisions
(Created page with "{{Chembox | ImageFile = TILMICOSIN2.png | ImageSize = 300px | IUPACName = [(2''R'',3''R'',4''E'',6''E'',9''R'',11''R'',12''S'',13''S'',14''R'')-12-{[3,6-Dideoxy-3-(dimethylami...") |
m (Protected "Tilmicosin": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 35: | Line 35: | ||
}} | }} | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
'''Tilmicosin''' is a [[macrolide antibiotic]]. It is used in veterinary medicine for the treatment of | ==Overview== | ||
'''Tilmicosin''' is a [[macrolide antibiotic]]. It is used in veterinary medicine for the treatment of bovine respiratory disease and [[ovine respiratory disease]] associated with ''Mannheimia (Pasteurella) haemolytica''.<ref>[http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm115928.pdf Micotil 300 New Animal Drug Application], [[United States Food and Drug Administration]]</ref> | |||
==References== | ==References== | ||
Line 42: | Line 47: | ||
[[Category:Macrolide antibiotics]] | [[Category:Macrolide antibiotics]] | ||
[[Category: | [[Category:Drug]] |
Latest revision as of 17:17, 20 August 2015
Names | |
---|---|
IUPAC name
[(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-Dideoxy-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-11-{2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]ethyl}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxooxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside
| |
Other names
Micotil; 20-Deoxy-20-(3,5-dimethylpiperidin-1-yl)-desmycosin[1]
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C46H80N2O13 | |
Molar mass | 869.15 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
WikiDoc Resources for Tilmicosin |
Articles |
---|
Most recent articles on Tilmicosin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tilmicosin at Clinical Trials.gov Clinical Trials on Tilmicosin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tilmicosin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tilmicosin Discussion groups on Tilmicosin Patient Handouts on Tilmicosin Directions to Hospitals Treating Tilmicosin Risk calculators and risk factors for Tilmicosin
|
Healthcare Provider Resources |
Causes & Risk Factors for Tilmicosin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tilmicosin is a macrolide antibiotic. It is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica.[2]